Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A clinical reference for prescribers and pharmacists covering hypoglycemia, weight gain, injection-site reactions, and other adverse events associated with basal insulin analogs, with evidence-based management protocols and dosing guidance.
Read clinical reviewA practical MD/PharmD-level guide to billing codes, prior-authorization strategy, and formulary navigation for basal insulin analogs including glargine, detemir, and degludec in T1D and T2D.
Read clinical reviewA prescriber-level monograph covering the pharmacology, clinical evidence, dosing, safety, and comparative data for all approved basal insulin analogs, including glargine U-100, glargine U-300, detemir, and degludec.
Read clinical reviewA comprehensive drug-drug interaction table for basal insulin analogs (glargine, detemir, degludec), with mechanism, severity, and clinical management guidance for prescribers and pharmacists.
Read clinical reviewA board-reviewed, evidence-based summary of basal insulin analog pharmacology, dosing, and special-population considerations for clinicians who prescribe or dispense these agents in T1D and T2D.
Read clinical reviewA clinician-level review of basal insulin analogs covering drug class pharmacology, monitoring parameters, dosing titration, safety, and prescribing guidance for T1D and T2D.
Read clinical reviewA clinical comparison of basal insulin analogs, glargine U-100, glargine U-300, detemir, and degludec, with dosing, titration, and patient-selection guidance for prescribers.
Read clinical reviewA prescriber-level guide to basal insulin analog titration and tapering algorithms for T1D and T2D, including starting doses, adjustment protocols, and deprescribing strategies backed by clinical trial data.
Read clinical review